News

Shares of Moderna MRNA rose nearly 6% yesterday after the U.S. Centers for Disease Control and Prevention (“CDC”) adopted new ...
The new vaccine committee appointed by Secretary Robert F. Kennedy Jr. took minimal action in its first meeting.
Compared to the standard shot, the mRNA vaccine had an overall vaccine efficacy that was 26.6 percent higher, and 27.4 ...
The Food and Drug Administration has approved three vaccines for RSV — GSK's GSK.L Arexvy, Moderna's MRNA.O mRESVIA and ...
A top official at the Food and Drug Administration recently overruled government scientists on the availability of two ...
The biotechnology company’s messenger RNA flu vaccine candidate showed positive results in a late-stage trial.
Chronic heart failure and hypoalbuminaemia are linked to a poor antibody response at 3 months after the third dose of the ...
The new results helped boost Moderna’s stock by more than 4% in early trading Monday, though the company’s shares are still down about 32% for the year. Moderna has more on the science behind mRNA.
Records show that a top U.S. regulator rejected the recommendations of agency experts and limited the use of Covid vaccines.
In adults 50 and older, Moderna’s flu shot was more than 26% better than an unspecified commercial vaccine. In May, the ...
Two young elephants at the Zoo, Sanjay and Kabir, overcame a deadly virus thanks to a new vaccine introduced to zoos ...
Two young male elephants, Sanjay and Kabir, who were vaccinated in 2024, later tested positive for Elephant Endotheliotropic ...